Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine
- PMID: 6093054
- PMCID: PMC320200
- DOI: 10.1093/nar/12.20.7787
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine
Abstract
The complete nucleotide sequence has been determined of a strain of poliovirus type 3, P3/119, isolated from the central nervous system of a victim of fatal vaccine-associated poliomyelitis. Comparison of this sequence with those obtained previously for the Sabin type 3 vaccine, P3/Leon 12a1b and its neurovirulent progenitor, P3/Leon/37, reveals that these three strains are on a direct geneaological lineage and therefore that P3/119 is a bona fide revertant of the vaccine. P3/119 differs in sequence from its attenuated vaccine parent at just seven positions. Only one of these differences, a mutation from U to C at position 472 in the presumed noncoding region of the genome, is a back mutation to the wild type sequence. Of the six other differences, three give rise to coding changes in virus structural proteins, two are silent changes in the major open reading frame of the genome and one affects the 3'-terminus just prior to the poly A tract. These differences indicate that there are three possible types of molecular change which could, singly or collectively, result in attenuation and reversion to neurovirulence of the Sabin type 3 vaccine.
Similar articles
-
Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.Virology. 1990 Mar;175(1):103-9. doi: 10.1016/0042-6822(90)90190-3. Virology. 1990. PMID: 2155504
-
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.Proc Natl Acad Sci U S A. 1984 Mar;81(5):1539-43. doi: 10.1073/pnas.81.5.1539. Proc Natl Acad Sci U S A. 1984. PMID: 6324200 Free PMC article.
-
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.J Virol. 1989 Mar;63(3):1338-44. doi: 10.1128/JVI.63.3.1338-1344.1989. J Virol. 1989. PMID: 2536836 Free PMC article.
-
The attenuation of poliovirus neurovirulence.Annu Rev Microbiol. 1987;41:153-80. doi: 10.1146/annurev.mi.41.100187.001101. Annu Rev Microbiol. 1987. PMID: 2825586 Review. No abstract available.
-
Attenuation and reversion of the Sabin vaccine strains of poliovirus.Dev Biol Stand. 1993;78:17-26. Dev Biol Stand. 1993. PMID: 8388828 Review.
Cited by
-
Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs.Enzymes. 2021;49:315-354. doi: 10.1016/bs.enz.2021.07.002. Epub 2021 Oct 15. Enzymes. 2021. PMID: 34696837 Free PMC article.
-
Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3.J Virol. 2004 Oct;78(20):11097-107. doi: 10.1128/JVI.78.20.11097-11107.2004. J Virol. 2004. PMID: 15452230 Free PMC article.
-
Enterovirus related metabolic myopathy: a postviral fatigue syndrome.J Neurol Neurosurg Psychiatry. 2003 Oct;74(10):1382-6. doi: 10.1136/jnnp.74.10.1382. J Neurol Neurosurg Psychiatry. 2003. PMID: 14570830 Free PMC article.
-
Comparative pathogenesis and systems biology for biodefense virus vaccine development.J Biomed Biotechnol. 2010;2010:236528. doi: 10.1155/2010/236528. Epub 2010 Jun 6. J Biomed Biotechnol. 2010. PMID: 20617142 Free PMC article. Review.
-
Fidelity Variants and RNA Quasispecies.Curr Top Microbiol Immunol. 2016;392:303-22. doi: 10.1007/82_2015_483. Curr Top Microbiol Immunol. 2016. PMID: 26499340 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources